Cover Image
市場調查報告書

細胞健康篩檢/健康試驗的全球市場的預測 ∼2022年:單一試驗板 (端粒、氧化壓力、發炎、重金屬檢)、多試驗板

Cellular Health Screening/Health Testing Market by Type (Single (Telomere, Oxidative Stress, Inflammation, Heavy Metal), Multitest), Sample (Blood, Saliva, Serum, Urine), Collection Site, and Region - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 531438
出版日期 內容資訊 英文 143 Pages
訂單完成後即時交付
價格
Back to Top
細胞健康篩檢/健康試驗的全球市場的預測 ∼2022年:單一試驗板 (端粒、氧化壓力、發炎、重金屬檢)、多試驗板 Cellular Health Screening/Health Testing Market by Type (Single (Telomere, Oxidative Stress, Inflammation, Heavy Metal), Multitest), Sample (Blood, Saliva, Serum, Urine), Collection Site, and Region - Global Forecast to 2022
出版日期: 2017年07月14日 內容資訊: 英文 143 Pages
簡介

全球細胞健康篩檢/健康試驗的市場在預測期間內,預計以10.0%的年複合成長率發展,從2017年的21億2000萬美元,成長到2022年的34億2000萬美元的規模。引導健康的端粒性能計劃的引進擴大,對健康延壽的焦點擴大,政府著重預防醫療,高齡人口的增加伴隨的細胞篩檢的需求擴大,研究活動的活躍等要素促進該市場的成長。

本報告提供全球細胞健康篩檢/健康試驗的市場調查,市場定義和概要,市場成長的各種影響因素及市場機會分析,各檢驗類型、樣品類型、樣品採取處、地區的趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 市場規模的變化與預測:各樣品採取網站
  • 各類型市場
  • 市場成果:單一試驗板
  • 各樣品類型市場
  • 地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 課題
    • 趨勢

第6章 市場分析:各類型

  • 簡介
  • 單一試驗板
    • 端粒檢驗
    • 氧化壓力
    • 發炎檢驗
    • 重金屬檢驗
  • 多試驗板

第7章 市場分析:各樣品類型

  • 簡介
  • 血液
  • 其他

第8章 市場分析:各樣品採取網站

  • 簡介
  • 家庭
  • 醫院
  • 其他

第9章 市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞洲
  • 其他地區

第10章 競爭環境

  • 簡介
  • 企業排行榜
  • 競爭領導製圖
  • 競爭基準
    • 產業策略
    • 產品系列

第11章 企業簡介

  • TELOMERE DIAGNOSTICS, INC. (TDX)
  • SPECTRACELL LABORATORIES
  • LIFE LENGTH
  • REPEAT DIAGNOSTICS INC. (REPEAT DX)
  • TITANOVO
  • CELL SCIENCE SYSTEMS
  • QUEST DIAGNOSTICS
  • LABCORP HOLDINGS
  • BIOREFRENCE LABORATORIES
  • CLEVELAND HEARTLAB, INC.
  • GENOVA DIAGNOSTICS
  • ZIMETRY LLC
  • IMMUNDIAGNOSTIK AG
  • SEGTERRA, INC.
  • DNA LABS INDIA

第12章 附錄

目錄
Product Code: BT 5413

"Cellular health screening market projected to grow at a CAGR of 10.0% from 2017 to 2022."

The global cellular health screening market is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion in 2017, at a CAGR of 10.0% during the forecast period. Increasing adoption of telomere performance programs for leading a healthy life; growing focus on increasing healthy life expectancy (HALE); increasing government focus towards preventive healthcare; rising geriatric population and the subsequent growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach for the availability of kits; and increasing burden of chronic diseases are driving the growth of the global cellular health screening market. On the other hand, problems associated with the transport of samples and differences in the cost of test kits offered by different companies may hinder the growth of the market in the coming years.

"The multi-test panels are expected to witness high growth during the forecast period."

Based on type, the global cellular health screening market is segmented into single test panels and multi-test panels. Multi-test panels are expected to register the highest CAGR during the forecast period. The preference for multi-test panels is increasing in the market as they provide results for multiple biomarkers in a single exam.

"Blood samples to dominate the global cellular health screening market in 2017."

Based on sample type, the global cellular health screening market is segmented into blood samples and other samples. The blood samples segment is expected to dominate this market with the largest share in 2017. The large share and high growth of this segment can primarily be attributed to the advantages associated with the use of blood samples, such as the accuracy and reliability of test results.

"North America to dominate the market and Asia to witness high growth during the forecast period."

In 2017, North America is expected to account for the largest share of the global cellular health screening market. Factors such as growing government focus towards preventive healthcare, increasing burden of chronic diseases, increasing research activities, rising geriatric population, and growing number of local players operating in the region are supporting the growth of the global cellular health screening market in the region. Also, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the rising geriatric population, increasing burden of chronic diseases, expansion opportunities for market players, and growing number of initiatives to create awareness about healthy lifestyles and preventive healthcare in several Asian countries.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 36%; Tier 2 - 41%; Tier 3 - 23%.
  • By Designation (Supply Side): C-level- 46%; D-level- 29%; Others- 25%.
  • By Region: North America-40%; Europe-20%; Asia-33%; RoW-7%.

List of Companies Profiled in the Report:

  • Genova Diagnostics
  • Telomere Diagnostics
  • Life Length
  • Quest Diagnostics
  • Repeat Diagnostics
  • SpectraCell Laboratories
  • Zimetry LLC
  • Cell Science Systems
  • Titanovo, Inc.
  • Segterra, Inc.
  • LabCorp Holdings
  • BioReference Laboratories
  • Immundiagnostik AG
  • Cleveland HeartLab, Inc.
  • DNA Labs India

Research Coverage:

The report provides an overview of the global cellular health screening market. It aims at estimating the market size and future growth potential of this market across different segments such as type, sample type, sample collection sites, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of the revenue numbers for the overall global cellular health screening market and its subsegments. This report will help stakeholders to understand the competitor landscape better and gain insights to position their businesses better and make suitable go-to-market strategies. The report also will help the stakeholders understand the pulse of the market and provide them with information regarding key market drivers, restraints challenges, and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
  • 2.2. PRIMARY DATA
  • 2.3. KEY INDUSTRY INSIGHTS
  • 2.4. MARKET SIZE ESTIMATION
  • 2.5. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CELLULAR HEALTH SCREENING MARKET: MARKET OVERVIEW
  • 4.2. CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE COLLECTION SITE, 2017-2022
  • 4.3. CELLULAR HEALTH SCREENING MARKET, BY TYPE
  • 4.4. CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS (2017)
  • 4.5. CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE
  • 4.6. GEOGRAPHIC SNAPSHOT OF THE CELLULAR HEALTH SCREENING MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing adoption of telomere performance programs for leading a healthy life
      • 5.2.1.2. Growing importance of healthy life expectancy (HALE)
      • 5.2.1.3. Rising government focus towards preventive healthcare
      • 5.2.1.4. Rising geriatric population and resultant growth in the need for cellular health screening
      • 5.2.1.5. Increasing research activities
      • 5.2.1.6. Growing adoption of direct-to-consumer approach for the availability of kits
      • 5.2.1.7. Increasing burden of chronic diseases
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Problems associated with the transport of samples
      • 5.2.2.2. Differences in the cost of test kits offered by different companies
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Potential applications of cellular health screening in precision and personalized medicine
      • 5.2.3.2. Expansion in emerging economies
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Limited reimbursement
    • 5.2.5. TRENDS
      • 5.2.5.1. Adoption of digital technologies for testing
      • 5.2.5.2. Label-free detection technologies are set to transform the market
      • 5.2.5.3. NGS-based Telomere length measurement techniques

6. CELLULAR HEALTH SCREENING MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. SINGLE TEST PANELS
    • 6.2.1. TELOMERE TESTS
    • 6.2.2. OXIDATIVE STRESS TESTS
    • 6.2.3. INFLAMMATION TESTS
    • 6.2.4. HEAVY METALS TESTS
  • 6.3. MULTI-TEST PANELS

7. CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE

  • 7.1. INTRODUCTION
  • 7.2. BLOOD SAMPLES
  • 7.3. OTHER SAMPLES

8. CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE

  • 8.1. INTRODUCTION
  • 8.2. AT-HOME SAMPLE COLLECTION
  • 8.3. IN-OFFICE SAMPLE COLLECTION
  • 8.4. OTHER SITES

9. CELLULAR HEALTH SCREENING MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Rising geriatric population and subsequent growth in the prevalence of chronic diseases
      • 9.2.1.2. Increasing initiatives for preventive healthcare
      • 9.2.1.3. Presence of major market players in the U.S.
    • 9.2.2. CANADA
      • 9.2.2.1. Government initiatives to promote a healthy lifestyle
      • 9.2.2.2. Growing research activities
  • 9.3. EUROPE
    • 9.3.1. INCREASING BURDEN OF CHRONIC DISEASES
    • 9.3.2. INITIATIVES TO CREATE AWARENESS ABOUT CELLULAR BIOMARKERS
    • 9.3.3. INITIATIVES BY GOVERNMENTS AND MAJOR MARKET PLAYERS
  • 9.4. ASIA
    • 9.4.1. RISING GERIATRIC POPULATION AND INCREASING BURDEN OF CHRONIC DISEASES
    • 9.4.2. EXPANSION OPPORTUNITIES FOR MARKET PLAYERS
    • 9.4.3. INITIATIVES TO CREATE AWARENESS ON HEALTHY LIFESTYLES AND PREVENTIVE HEALTHCARE
  • 9.5. REST OF THE WORLD
    • 9.5.1. GROWING PREVALENCE OF CHRONIC DISEASES
    • 9.5.2. INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
    • 9.5.3. STRATEGIC INITIATIVES BY MARKET PLAYERS

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. COMPANY RANKING: TELOMERE TESTING MARKET
  • 10.3. COMPETITIVE LEADERSHIP MAPPING
    • 10.3.1. VISIONARY LEADERS
    • 10.3.2. INNOVATORS
    • 10.3.3. DYNAMIC DIFFERENTIATORS
    • 10.3.4. EMERGING COMPANIES
  • 10.4. COMPETITIVE BENCHMARKING
    • 10.4.1. BUSINESS STRATEGIES EXCELLENCE
    • 10.4.2. STRENGTH OF PRODUCT PORTFOLIO

Top 25 companies analyzed for this study are - Genova Diagnostics; Quest Diagnostics; Life Length; Zimetry LLC; Telomere Diagnostics; Repeat Diagnostics; SpectraCell Laboratories; Cell Science Systems; Titanovo, Inc.; InsideTracker; DNA LABS India; Laboratory Corporation of America Holdings; Cleveland HeartLab, Inc.; BioReference Laboratories; Immundiagnostik AG; Spectra Laboratories; Cell Biolabs Inc.; AML Diagnostics; Enzo Clinical Lab; Access Medical Labs; Life Line Screening; Mayo Medical Laboratories; Clinical Reference Labotory; Synlab Internatinal; ACM Medical Laboratory

11. COMPANY PROFILES (Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships)*

  • 11.1. TELOMERE DIAGNOSTICS, INC. (TDX)
  • 11.2. SPECTRACELL LABORATORIES
  • 11.3. LIFE LENGTH
  • 11.4. REPEAT DIAGNOSTICS INC. (REPEAT DX)
  • 11.5. TITANOVO
  • 11.6. CELL SCIENCE SYSTEMS
  • 11.7. QUEST DIAGNOSTICS
  • 11.8. LABCORP HOLDINGS
  • 11.9. BIOREFRENCE LABORATORIES
  • 11.10. CLEVELAND HEARTLAB, INC.
  • 11.11. GENOVA DIAGNOSTICS
  • 11.12. ZIMETRY LLC
  • 11.13. IMMUNDIAGNOSTIK AG
  • 11.14. SEGTERRA, INC.
  • 11.15. DNA LABS INDIA

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: LIFE EXPECTANCY AND HEALTHY LIFE EXPECTANCY AT BIRTH, BY REGION (YEARS)
  • TABLE 2: LIFE EXPECTANCY AND HEALTHY LIFE EXPECTANCY FOR INDIVIDUALS AGED 60 YEARS, BY REGION (YEARS)
  • TABLE 3: GOVERNMENT INITIATIVES TO PROMOTE LIFE SCIENCE RESEARCH
  • TABLE 4: INITIATIVES FROM PRIVATE ORGANIZATIONS TO PROMOTE LIFE SCIENCE RESEARCH
  • TABLE 5: GLOBAL CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: SINGLE TEST PANELS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 7: SINGLE TEST PANELS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: NORTH AMERICA: SINGLE TEST PANELS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: TELOMERE TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: NORTH AMERICA: TELOMERE TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: OXIDATIVE STRESS TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: NORTH AMERICA: OXIDATIVE STRESS TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: DEVELOPMENTS IN THE INFLAMMATION TESTS MARKET
  • TABLE 14: INFLAMMATION TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: NORTH AMERICA: INFLAMMATION TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 16: HEAVY METALS TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NORTH AMERICA: HEAVY METALS TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: MULTI-TEST PANELS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: NORTH AMERICA: MULTI-TEST PANELS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: GLOBAL CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 21: DEVELOPMENTS IN THE BLOOD TESTS MARKET
  • TABLE 22: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: EUROPE: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: ASIA: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: EUROPE: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: ASIA: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: GLOBAL CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015-2022 (USD MILLION)
  • TABLE 31: CELLULAR HEALTH SCREENING MARKET SIZE FOR AT-HOME SAMPLE COLLECTION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET SIZE FOR AT-HOME SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: EUROPE: CELLULAR HEALTH SCREENING MARKET FOR AT-HOME SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: CELLULAR HEALTH SCREENING MARKET SIZE FOR IN-OFFICE SAMPLE COLLECTION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET SIZE FOR IN-OFFICE SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: CELLULAR HEALTH SCREENING MARKET FOR IN-OFFICE SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 37: GLOBAL CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLE COLLECTION SITES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLE COLLECTION SITES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLE COLLECTION SITES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: CELLULAR HEALTH SCREENING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015-2022 (USD MILLION)
  • TABLE 46: U.S.: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: U.S.: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: U.S.: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 49: U.S.: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015-2022 (USD MILLION)
  • TABLE 50: CANADA: RESEARCH ACTIVITIES IN THE FIELD OF CELLULAR HEALTH
  • TABLE 51: CANADA: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: CANADA: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 53: CANADA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: CANADA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015-2022 (USD MILLION)
  • TABLE 55: EUROPE: IMPORTANT EVENTS FOCUSING ON CELLULAR BIOMARKERS
  • TABLE 56: EUROPE: CELLULAR HEALTH SCREENING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 57: EUROPE: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: EUROPE: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: EUROPE: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: EUROPE: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA: CELLULAR HEALTH SCREENING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: ASIA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: ASIA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015-2022 (USD MILLION)
  • TABLE 66: ROW: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: ROW: CELLULAR HEALTH SCREENING MARKET FOR SINGLE-TEST PANELS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: ROW: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: ROW: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015-2022 (USD MILLION)
  • TABLE 70: RANKING OF TOP PLAYERS IN THE TELOMERE TESTING MARKET
  • TABLE 71: REPEAT DX: LIST OF ACCREDITATIONS

LIST OF FIGURES

  • FIGURE 1: GLOBAL CELLULAR HEALTH SCREENING: MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 4: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 5: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 7: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: CELLULAR HEALTH SCREENING MARKET SIZE, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE COLLECTION SITE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 12: NORTH AMERICA TO DOMINATE THE CELLULAR HEALTH SCREENING MARKET DURING THE FORECAST PERIOD
  • FIGURE 13: RISING FOCUS TOWARDS PREVENTIVE HEALTHCARE IS EXPECTED TO DRIVE THE GLOBAL CELLULAR HEALTH SCREENING MARKET
  • FIGURE 14: AT-HOME SAMPLE COLLECTION SEGMENT TO DOMINATE THE CELLULAR HEALTH SCREENING MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: MULTI-TEST PANELS SEGMENT TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
  • FIGURE 16: INFLAMMATION TESTS TO COMMAND THE LARGEST SHARE OF THE CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS IN 2017
  • FIGURE 17: BLOOD SAMPLES SEGMENT TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
  • FIGURE 18: ASIAN MARKET PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 19: CELLULAR HEALTH SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE
  • FIGURE 20: SINGLE TEST PANELS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: BLOOD SAMPLES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: AT-HOME SAMPLE COLLECTION SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 23: NORTH AMERICA TO DOMINATE THE CELLULAR HEALTH SCREENING MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
  • FIGURE 25: PREVALENCE OF CORONARY HEART DISEASE BY AGE AND SEX (2009-2012)
  • FIGURE 26: EUROPE: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
  • FIGURE 27: ASIA: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
  • FIGURE 28: ROW: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
  • FIGURE 29: GLOBAL CELLULAR HEALTH SCREENING MARKET, COMPETITIVE LEADERSHIP MAPPING 2017
  • FIGURE 30: QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2016)
  • FIGURE 31: LABCORP HOLDINGS: COMPANY SNAPSHOT (2016)
  • FIGURE 32: OPKO HEALTH, INC.: COMPANY SNAPSHOT (2016)
Back to Top